These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 19075624)

  • 21. Development of an Rev-independent, minimal simian immunodeficiency virus-derived vector system.
    Pandya S; Boris-Lawrie K; Leung NJ; Akkina R; Planelles V
    Hum Gene Ther; 2001 May; 12(7):847-57. PubMed ID: 11339901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene therapy of the central nervous system: general considerations on viral vectors for gene transfer into the brain.
    Serguera C; Bemelmans AP
    Rev Neurol (Paris); 2014 Dec; 170(12):727-38. PubMed ID: 25459120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors.
    Brooks AI; Stein CS; Hughes SM; Heth J; McCray PM; Sauter SL; Johnston JC; Cory-Slechta DA; Federoff HJ; Davidson BL
    Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6216-21. PubMed ID: 11959904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-2 and SIV vector systems.
    Gilbert JR; Wong-Staal F
    Somat Cell Mol Genet; 2001 Nov; 26(1-6):83-98. PubMed ID: 12465463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lentiviral vectors and gene therapy.
    Klimatcheva E; Rosenblatt JD; Planelles V
    Front Biosci; 1999 Jun; 4():D481-96. PubMed ID: 10352135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lentiviral vectors for gene therapy of HIV-1 infection.
    Mautino MR
    Curr Gene Ther; 2002 Feb; 2(1):23-43. PubMed ID: 12108972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Large animal models of neurological disorders for gene therapy.
    Gagliardi C; Bunnell BA
    ILAR J; 2009; 50(2):128-43. PubMed ID: 19293458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lentiviral vectors for gene delivery into cells.
    Quinonez R; Sutton RE
    DNA Cell Biol; 2002 Dec; 21(12):937-51. PubMed ID: 12573051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The molecular genetics of lentiviral vectors--current and future perspectives.
    Chang LJ; Gay EE
    Curr Gene Ther; 2001 Sep; 1(3):237-51. PubMed ID: 12109139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-Titer Production of HIV-Based Lentiviral Vectors in Roller Bottles for Gene and Cell Therapy.
    Olgun HB; Tasyurek HM; Sanlioglu AD; Sanlioglu S
    Methods Mol Biol; 2019; 1879():323-345. PubMed ID: 29797007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene therapy for neurodegenerative diseases based on lentiviral vectors.
    Nanou A; Azzouz M
    Prog Brain Res; 2009; 175():187-200. PubMed ID: 19660657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of nonintegrating lentiviral vectors for gene therapy.
    Philpott NJ; Thrasher AJ
    Hum Gene Ther; 2007 Jun; 18(6):483-9. PubMed ID: 17523890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene Therapy, A Novel Therapeutic Tool for Neurological Disorders: Current Progress, Challenges and Future Prospective.
    Iqubal A; Iqubal MK; Khan A; Ali J; Baboota S; Haque SE
    Curr Gene Ther; 2020; 20(3):184-194. PubMed ID: 32674730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lentivirus and foamy virus vectors: novel gene therapy tools.
    Pandya S; Klimatcheva E; Planelles V
    Expert Opin Biol Ther; 2001 Jan; 1(1):17-40. PubMed ID: 11727544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel bovine lentiviral vectors based on Jembrana disease virus.
    Metharom P; Takyar S; Xia HH; Ellem KA; Macmillan J; Shepherd RW; Wilcox GE; Wei MQ
    J Gene Med; 2000; 2(3):176-85. PubMed ID: 10894263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotection in a rat Parkinson model by GDNF gene therapy using EIAV vector.
    Azzouz M; Ralph S; Wong LF; Day D; Askham Z; Barber RD; Mitrophanous KA; Kingsman SM; Mazarakis ND
    Neuroreport; 2004 Apr; 15(6):985-90. PubMed ID: 15076720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors.
    Poeschla EM; Wong-Staal F; Looney DJ
    Nat Med; 1998 Mar; 4(3):354-7. PubMed ID: 9500613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector.
    Yamada K; Olsen JC; Patel M; Rao KW; Walsh CE
    Mol Ther; 2001 Apr; 3(4):485-90. PubMed ID: 11319908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strategies for targeting lentiviral vectors.
    Frecha C; Szécsi J; Cosset FL; Verhoeyen E
    Curr Gene Ther; 2008 Dec; 8(6):449-60. PubMed ID: 19075628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression from second-generation feline immunodeficiency virus vectors is impaired in human hematopoietic cells.
    Price MA; Case SS; Carbonaro DA; Yu XJ; Petersen D; Sabo KM; Curran MA; Engel BC; Margarian H; Abkowitz JL; Nolan GP; Kohn DB; Crooks GM
    Mol Ther; 2002 Nov; 6(5):645-52. PubMed ID: 12409263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.